Fundz

Werewolf Therapeutics, Inc. reported raising $31.6 Million in an initial SEC Form D filing, from an offering of $57.7 Million

PUBLIC · HOWLAug 15, 2019$31.6M of $57.7M raised

Amount Raised

$31.6 Million

$31.6 Million sold, per SEC Form D (first sale Aug 15, 2019)

Round Type

Venture

WatertownBiotechnologyHealthcareHealth CareTherapeutics

Quick answer

Werewolf Therapeutics raised $31.6 Million in a funding round, dated August 15, 2019. Werewolf Therapeutics is based in Watertown, Massachusetts, United States.

How much did Werewolf Therapeutics raise?
Werewolf Therapeutics raised $31.6 Million in a funding round on August 15, 2019.
What does Werewolf Therapeutics do?
Werewolf Therapeutics, Inc. is an innovative clinical-stage biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.
Where is Werewolf Therapeutics based and how big is it?
Werewolf Therapeutics is based in Watertown, Massachusetts, United States. Fundz records about 23 employees.
Who are the decision-makers at Werewolf Therapeutics?
Fundz holds 2 contacts at Werewolf Therapeutics, including the Founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Werewolf Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Renibus Therapeutics raised $3.4M on September 23, 2019.
  • Passage Bio raised $110M on September 6, 2019.
  • Vaccinex raised $14M on August 14, 2019.
  • Recursion Pharmaceuticals raised $122M on August 13, 2019.
  • Chimerix raised $35M on July 31, 2019.
  • Solid Biosciences raised $60M on July 31, 2019.

Who to call at Werewolf Therapeutics, and when

A new round usually means Werewolf Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Werewolf Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Werewolf Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Werewolf Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Werewolf Therapeutics

Location

200 Talcott Ave, 2nd Floor

Watertown, Massachusetts, United States

About

Werewolf Therapeutics, Inc. is an innovative clinical-stage biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. We are leveraging our proprietary PREDATORTM platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Our INDUKINETM molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment. Our most advanced product candidates, WTX-124 and WTX-330, are systemically delivered, conditionally activated Interleukin-2 (IL-2), and Interleukin-12 (IL-12) INDUKINE molecules for the treatment of solid tumors. WTX-124 is in development as a monotherapy and in combination with KEYTRUDA® (pembrolizumab) in multiple solid tumor types. WTX-330 is in development as a single agent in refractory and/or immunotherapy unresponsive or resistant advanced or metastatic solid tumors and non-Hodgkin lymphoma.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Werewolf Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsDan H., Founder hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Werewolf Therapeutics's next move

See what Strategic adds

Werewolf Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.